JAMPJ HID RISPERDAL STUDIES TO BOOST DRUG SALES LAWYER SAYS

February 3, 2012

Johnson & Johnson hid studies showing its Risperdal anti-psychotic drug caused diabetes to protect billions of dollars in sales, a lawyer said in the first personal-injury claim over the medication to go to trial.



Full Story Below

Rapid Response
Free Case Evaluation


The Help You Need,
When You Need it Most

Please Type The Number You See Below

4156

More from National News Directory

Claim Your Attorney Profile
Lawyer Central Legal Sites
  Injury     Bankruptcy     Dangerous Products     Family     Real Estate     Estate Planning     Immigration     Disability     Employment     Toxic Torts     Criminal     Litigation  

Find us on Facebook! Follow us on Twitter!

Lawyer State Directories
Alabama | Alaska | Arizona | Arkansas | California | Colorado | Connecticut | Delaware | Florida | Georgia | Hawaii | Idaho | Illinois | Indiana | Iowa | Kansas | Kentucky | Louisiana | Maine | Maryland | Massachusetts | Michigan | Minnesota | Mississippi | Missouri | Montana | Nebraska | Nevada | New Hampshire | New Jersey | New Mexico | New York | North Carolina | North Dakota | Ohio | Oklahoma | Oregon | Pennsylvania | Rhode Island | South Carolina | South Dakota | Tennessee | Texas | Utah | Vermont | Virginia | Washington | West Virginia | Wisconsin | Wyoming |
May 26, 2012
Terms & Conditions
Site Map


Follow @lawyercentral